Life Sciences Pulse

Targeting growth equity investments in highly innovative life sciences businesses

The strategy seeks to invest in companies operating in specific areas of innovation, including therapeutics, diagnostics, and life sciences tools. By leveraging Sands Capital’s global research platform to source, assess, and structure investment opportunities, Sands Capital partners with pioneers in the expanding class of innovative life sciences businesses.

This investment strategy is executed by Sands Capital Ventures, LLC, an affiliate of Sands Capital Management, LLC. Sands Capital Management is the investment adviser that provides Sands Capital’s Public Growth investment strategies. Sands Capital Management seeks to adhere to the Global Investment Performance Standards (GIPS®) when reporting its investment performance results; however, Sands Capital Ventures currently does not.

Our Investment Focus

In addition to the six criteria that guide all investment decisions at Sands Capital, Life Sciences Pulse invests in businesses that fit the following criteria:

Investment Focus blue magnifier ICON

Sector

Innovative life sciences business who are leaders in therapeutics,  diagnostics, and life sciences tools

Stage Focus blue arrow pointing up graph ICON

Stage

Businesses with meaningful clinical data, proof of concept data, and/or promising business models

Geographic Focus blue globe icon

Geography

Targeting major innovation hubs around the globe

Portfolio Construction blue circle icon

Concentration

$15 million – $30 million target investment size per company

Portfolio Businesses

Strategy Team

A bold mission requires a strong team. We sought out individuals who share our passion and have assembled a deep and diverse bench of investment, legal, operational, and financial personnel to execute on our mission.

Daniel H. Cheng

Daniel H. Cheng

Research Analyst

Michael J. Ginder, CFA

Michael J. Ginder, CFA

Research Analyst

Andrew P. Giordano

Andrew P. Giordano

Sr. Director, Client Relations

Jennifer A. Goldsmith

Jennifer A. Goldsmith

Research Analyst
Director, Research Associate Program

Jonathan P. Goodman

Jonathan P. Goodman

General Counsel

Yolande J. Hanlan

Yolande J. Hanlan

Director, Sr. Counsel

Jake Merrill, CFA

Jake Merrill, CFA

Principal

Ian Ratcliffe

Ian Ratcliffe

Managing Partner

Frank M. Sands, CFA

Frank M. Sands, CFA

Chief Investment Officer
Chief Executive Officer

Erin Soule, CPA

Erin Soule, CPA

Director of Finance & Operations

Stephen Zachary, PhD

Stephen Zachary, PhD

Partner